March 21, 2024 Webinar
This virtual webinar focused on launching the Clock Foundation's inaugural longevity research initiative - the AKG Testing Group. The session explored participatory research opportunities designed to validate anti-aging interventions through biomarker monitoring.
Key Topics Covered
Longevity Groups Initiative
The program facilitates group-based research exploring anti-aging effects of various supplements and protocols. Participants test interventions collectively while maintaining individual tracking, generating both personalized and aggregated insights on biological aging measures.
AKG Testing Group (Primary Focus)
The inaugural cohort investigates whether alpha-ketoglutarate supplementation affects epigenetic clocks and aging biomarkers over a 6-month period. Participants obtain their own AKG, follow a shared testing protocol, and share their biomarker data anonymously.
Longevity Tracker Portal Demo
Mark Koester demonstrated the software platform enabling participants to:
- Complete enrollment surveys
- Log weekly treatment compliance
- Track wearable data integration
- Access personalized biological age reports
Monthly Research Roundup
Bobby Brooke reviewed recent scientific developments including:
- Epigenetic clock validation studies
- Proteomics research on dementia prediction
- Mendelian randomization investigations
- Novel viral discoveries affecting microbiomes
Participation Requirements
- Enrollment survey completion
- Biological age testing subscription ($50-$150/month)
- AKG supplement ($40-$80/month)
- 6-month commitment with pre/post testing
Key Speakers
- Bobby Brooke - Executive Director, Clock Foundation
- Mark Koester - Head of Product, MyAgingTests.com
Reports & Resources Available
Participants receive:
- Individual longitudinal tracking reports
- GrimAge epigenetic age assessments
- PhenoAge clinical biomarker results
- Wearable data integration reports
- Group-level aggregate findings
